Trials / Unknown
UnknownNCT06215157
A Comparison of Stroke Volume Variation for Prediction of Fluid Responsiveness
A Comparison of Stroke Volume Variation for Prediction of Fluid Responsiveness Measured by Thoracic Electrical Bioimpedance and FloTrac/Vigileo
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Stroke volume variation (SVV) is an indicator used to assess the patient's volume status. The FloTrac system (Edwards Lifesciences, Irvine, CA) continuously monitors cardiac output (CO) and SVV (SVV-FloTrac) by analyzing the systemic arterial pressure wave. Numerous studies have demonstrated that SVV-FloTrac serves as a reliable indicator of fluid responsiveness. However, its peripheral invasiveness raises concerns about susceptibility to reflecting waves, damping, and vascular tone influences.In contrast, Transthoracic electrical bioimpedance (BioZ.com™) offers a non-invasive approach for continuously monitoring various hemodynamic variables. In this study, the primary aim was to assess the agreement between simultaneously measured SVV-FloTrac and SVV-BioZ.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Flotrac Group | Haemodynamic parameters were collected simultaneously by the Flotrac monitoring. |
| DEVICE | BioZ Group | Haemodynamic parameters were collected simultaneously by the thoracic bioimpedance (BioZ.com™)monitoring. |
Timeline
- Start date
- 2024-01-30
- Primary completion
- 2025-06-30
- Completion
- 2025-12-30
- First posted
- 2024-01-22
- Last updated
- 2024-01-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06215157. Inclusion in this directory is not an endorsement.